|Past two years||Past Year||Past 30 Days|
|Full Text Views||5||0||0|
Two cases of serum sickness from furazolidone (Furoxona®), prescribed for giardiasis in Latin America, are described. No previous case of serum sickness related to this drug has been reported in the United States. Tartrazine (yellow dye number 5), a component of furazolidone tablets (Furoxona) manufactured in Latin American countries but no longer included in the drug (Furoxone®) in the United States is suggested as a possible cause of serum sickness.
Presently Regional Medical Officer, American Embassy, Athens, Greece.